Article

Effectiveness of psychosocial treatments on suicidality in personality disorders.

Head, Borderline Personality Disorder Clinic, Centre for Addiction and Mental Health, Toronto, Ontario.
Canadian journal of psychiatry. Revue canadienne de psychiatrie (Impact Factor: 2.41). 07/2007; 52(6 Suppl 1):103S-114S.
Source: PubMed

ABSTRACT Axis II disorders, particularly borderline personality disorder, are highly associated with suicidal behaviours. This paper aims to evaluate treatment of suicidality in borderline personality disorder.
Systematic review of the empirical literature on the clinical effectiveness of psychosocial treatments in reducing suicidal behaviours in patients with personality disorders. A summary of empirical findings is presented, and recommendations for clinical practice are offered.
While there is currently a dearth of well-controlled treatment trials, interest in this field of research is growing, and several recent randomized controlled trials support the effectiveness of certain interventions.
Several different types of psychosocial interventions are associated with reductions in suicidal behaviour.

2 Followers
 · 
52 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Borderline personality disorder (BPD) is characterised by a pervasive and persistent pattern of instability and impulsivity. BPD has enjoyed much research attention for several decades both in terms of understanding it and tackling it. Whilst the label of BPD is frequently used in clinic settings dealing with teenagers its use in the young remains controversial. Nevertheless, many believe that a set of converging arguments makes its use legitimate in this age group (Miller et al, 2008). From a didactic perspective, this chapter uses the concept of BPD as defined in DSM 5. However, readers need to be aware of the risks of this reductionism in relation to other conceptualizations of the condition. In this chapter we highlight the high frequency of the disorder in adult and adolescent populations and its psychosocial consequences. A large section is dedicated to diagnosis and differential diagnosis. The chapter finishes with a description of useful treatment strategies. http://iacapap.org/wp-content/uploads/H.4-BORDERLINE-2015-UPDATE.pdf
    IACAPAP e-Textbook of Child and Adolescent Mental Health, 2015 edited by Rey JM, 05/2015: chapter H4: pages 1-17; International Association for Child and Adolescent Psychiatry and Allied Professions (IACAPAP), Geneva.
  • [Show abstract] [Hide abstract]
    ABSTRACT: The purpose of Study 1 was to examine the relative efficacy of evidence-based treatments (EBTs) when compared to treatment-as-usual (TAU) for adults diagnosed with a personality disorder (PD). The purpose of Study 2 was to investigate the strength of the differences between bona fide psychotherapeutic treatments for PDs. Two separate computerized searches were conducted of: (a) studies that directly compared an EBT with a TAU for treatment of PDs, or (b) studies that compared at least two bona fide treatments for PDs. Meta-analytic methods were used to estimate the effectiveness of the treatments when compared to one another and to model how various confounding variables impacted the results of this comparative research. A total of 30 studies (Study 1; N=1662) were included in the meta-analysis comparing EBTs to TAU. A total of 12 studies (Study 2; N=723) were included in the meta-analysis comparing bona fide treatments. Study 1 found that EBTs were superior to TAU, although the TAU conditions were not comparable in many respects (e.g., not psychotherapy, lacking supervision, lacking training, etc.) to the EBT and there was significant heterogeneity in the effects. Study 2 found that some bona fide treatments were superior to others.
    Clinical psychology review 08/2013; 33(8):1057-1066. DOI:10.1016/j.cpr.2013.08.003 · 7.18 Impact Factor
  • Source
    IACAPAP e-Textbook of Child and Adolescent mental Health, Edited by Rey JM, 01/2012: chapter Borderline personality disorder: pages Chapter H.4, 18 p; International Association for Child and Adolescent Psychiatry and Allied Professions, Geneva.